A Randomized Controlled Trial of the Cost-Utility of Second-Generation Antipsychotics in People with Psychosis and Eligible for Clozapine

Linda M. Davies; Thomas R.E. Barnes; Peter B. Jones; Shôn Lewis; Fiona Gaughran; Karen Hayhurst; Alison Markwick; Helen Lloyd

doi:10.1111/j.1524-4733.2007.00280.x

A Randomized Controlled Trial of the Cost-Utility of Second-Generation Antipsychotics in People with Psychosis and Eligible for Clozapine

Linda M. Davies, Thomas R.E. Barnes, Peter B. Jones, Shôn Lewis, Fiona Gaughran, Karen Hayhurst, Alison Markwick, Helen Lloyd

School of Psychology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	549-562
Number of pages	0
Journal	Value in Health
Volume	11
Issue number	4
DOIs	https://doi.org/10.1111/j.1524-4733.2007.00280.x
Publication status	Published - Jul 2008

Access to Document

10.1111/j.1524-4733.2007.00280.x

Cite this

@article{5a22f3a8ad584732894105e127c32eee,

title = "A Randomized Controlled Trial of the Cost-Utility of Second-Generation Antipsychotics in People with Psychosis and Eligible for Clozapine",

author = "Davies, {Linda M.} and Barnes, {Thomas R.E.} and Jones, {Peter B.} and Sh{\^o}n Lewis and Fiona Gaughran and Karen Hayhurst and Alison Markwick and Helen Lloyd",

year = "2008",

month = jul,

doi = "10.1111/j.1524-4733.2007.00280.x",

language = "English",

volume = "11",

pages = "549--562",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Ltd.",

number = "4",

}

TY - JOUR

T1 - A Randomized Controlled Trial of the Cost-Utility of Second-Generation Antipsychotics in People with Psychosis and Eligible for Clozapine

AU - Davies, Linda M.

AU - Barnes, Thomas R.E.

AU - Jones, Peter B.

AU - Lewis, Shôn

AU - Gaughran, Fiona

AU - Hayhurst, Karen

AU - Markwick, Alison

AU - Lloyd, Helen

PY - 2008/7

Y1 - 2008/7

U2 - 10.1111/j.1524-4733.2007.00280.x

DO - 10.1111/j.1524-4733.2007.00280.x

M3 - Article

SN - 1098-3015

VL - 11

SP - 549

EP - 562

JO - Value in Health

JF - Value in Health

IS - 4

ER -